magnetic_resonance_image-guided_laser_interstitial_thermal_therapy_for_intractable_mesial_temporal_epilepsy

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
magnetic_resonance_image-guided_laser_interstitial_thermal_therapy_for_intractable_mesial_temporal_epilepsy [2022/10/05 16:58] administradormagnetic_resonance_image-guided_laser_interstitial_thermal_therapy_for_intractable_mesial_temporal_epilepsy [2022/10/05 17:01] (current) – [Position Statement on Magnetic resonance image-guided laser interstitial thermal therapy for epilepsy] administrador
Line 34: Line 34:
  
 ===== Position Statement on Magnetic resonance image-guided laser interstitial thermal therapy for epilepsy ===== ===== Position Statement on Magnetic resonance image-guided laser interstitial thermal therapy for epilepsy =====
-[[Magnetic resonance image-guided laser interstitial thermal therapy]] (MRgLITT) is a tool in the neurosurgical [[armamentarium]] for the management of [[drug-resistant epilepsy]]. Given the introduction of this technology, the [[American Society for Stereotactic and Functional Neurosurgery]] (ASSFN), which acts as the joint section representing the field of stereotactic and functional neurosurgery on behalf of the [[Congress of Neurological Surgeons]] and the [[American Association of Neurological Surgeons]], provides here the [[expert consensus]] [[opinion]] on [[evidence]]-based [[best practices]] for the use and implementation of this treatment modality. Indications for treatment are outlined, consisting of failure to respond to, or intolerance of, at least 2 appropriately chosen medications at appropriate doses for disabling, localization-related epilepsy in the setting of well-defined epileptogenic foci, or critical pathways of seizure propagation accessible by MRgLITT. Applications of MRgLITT in mesial temporal lobe epilepsy and hypothalamic hamartoma, along with its contraindications in the treatment of epilepsy, are discussed based on current evidence. To put this [[position statement]] in perspective, they detailed the evidence and authority on which this ASSFN position statement is based+[[Magnetic resonance image-guided laser interstitial thermal therapy]] (MRgLITT) is a tool in the neurosurgical [[armamentarium]] for the management of [[drug-resistant epilepsy]]. Given the introduction of this technology, the [[American Society for Stereotactic and Functional Neurosurgery]] (ASSFN), which acts as the joint section representing the field of stereotactic and functional neurosurgery on behalf of the [[Congress of Neurological Surgeons]] and the [[American Association of Neurological Surgeons]], provides here the [[expert consensus]] [[opinion]] on [[evidence]]-based [[best practices]] for the use and implementation of this treatment modality. Indications for treatment are outlined, consisting of failure to respond to, or intolerance of, at least 2 appropriately chosen medications at appropriate doses for disabling, localization-related epilepsy in the setting of well-defined epileptogenic foci, or critical pathways of seizure propagation accessible by MRgLITT. Applications of MRgLITT in [[mesial temporal lobe epilepsy]] and [[hypothalamic hamartoma]], along with its contraindications in the treatment of epilepsy, are discussed based on current evidence. To put this [[position statement]] in perspective, they detailed the evidence and authority on which this ASSFN position statement is based
 ((Wu C, Schwalb JM, Rosenow JM, McKhann GM 2nd, Neimat JS; American Society for Stereotactic and Functional Neurosurgeons. The American Society for Stereotactic and Functional Neurosurgery Position Statement on Laser Interstitial Thermal Therapy for the Treatment of Drug-Resistant Epilepsy. Neurosurgery. 2022 Feb 1;90(2):155-160. doi: 10.1227/NEU.0000000000001799. PMID: 34995216.)) ((Wu C, Schwalb JM, Rosenow JM, McKhann GM 2nd, Neimat JS; American Society for Stereotactic and Functional Neurosurgeons. The American Society for Stereotactic and Functional Neurosurgery Position Statement on Laser Interstitial Thermal Therapy for the Treatment of Drug-Resistant Epilepsy. Neurosurgery. 2022 Feb 1;90(2):155-160. doi: 10.1227/NEU.0000000000001799. PMID: 34995216.))
  
  • magnetic_resonance_image-guided_laser_interstitial_thermal_therapy_for_intractable_mesial_temporal_epilepsy.txt
  • Last modified: 2022/10/05 17:01
  • by administrador